Recombinant Human HTR1E Protein，GST

HTR1E is a member of the 5-hydroxytryptamine (serotonin) receptor family, specifically belonging to the 5-HT1 receptor subtype. This receptor is primarily expressed in the central nervous system and plays a crucial role in various physiological processes, including mood regulation, anxiety, and the modulation of neurotransmitter release. Research into HTR1E has gained momentum due to its potential implications in neuropsychiatric disorders such as depression, anxiety disorders, and schizophrenia. The recombinant expression of HTR1E protein allows for detailed investigations into its structure, function, and pharmacological properties. By producing the protein in non-native systems, researchers can study receptor-ligand interactions, signaling pathways, and the receptor's role in downstream effects on neuronal activity. Understanding the molecular mechanisms of HTR1E could lead to the development of novel therapeutic agents targeting this receptor, offering hope for improved treatments for mental health conditions. Additionally, the study of HTR1E might provide insights into the evolutionary aspects of the serotonin receptor family, as variations in its expression and function may contribute to individual differences in behavior and susceptibility to mental health disorders. Overall, the exploration of HTR1E and its recombinant protein forms is vital for uncovering potential therapeutic targets and elucidating the neurobiological underpinnings of mood and anxiety disorders.